Aaron I. Davis's Insider Trades & SAST Disclosures
Aaron I. Davis's most recent trade in Tango Therapeutics Inc was a trade of 65,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 3, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Aaron I. Davis.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tango Therapeutics Inc | Aaron I. Davis | See remarks. | Other type of transaction at price $ 0.00 per share. | 03 Sep 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Aaron I. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 24,200 | 24,200 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Aaron I. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Aaron I. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Mirati Therapeutics Inc | Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 47,517 (0%) | 0% | 0 | Common Stock | |
| Tango Therapeutics Inc | Aaron I. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 43,073 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Aaron I. Davis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 40,527 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges